NDC Warrant Agreement


  
 Exhibit 10 (iv)

  
 NEITHER THIS WARRANT NOR THE SECURITIES THAT MAY BE ACQUIRED UPON THE
EXERCISE OF THIS WARRANT: (A) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES LAWS; AND (B) MAY BE SOLD, PLEDGED, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE
ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER THE SECURITIES ACT (INCLUDING ANY RULES OR REGULATIONS THEREUNDER) AND ANY APPLICABLE STATE SECURITIES LAWS. 
  
 NDCHEALTH CORPORATION 
  
 WARRANT AGREEMENT 
  
 THIS CERTIFIES that, for value received, ARCLIGHT SYSTEMS LLC, a Delaware limited liability company (the “Holder”), shall be entitled to
acquire from NDCHEALTH CORPORATION, a Delaware corporation (the “Company”), subject to the terms and conditions contained herein, at any time during the period from 9:00 A.M. (Eastern Standard Time) on January 1, 2007, through 5:00
P.M. (Eastern Standard Time) on December 31, 2008 (the “Exercise Period”), 381,098 shares (individually, a “Warrant Share” and collectively, the “Warrant Shares”) of “Common Stock” (as hereinafter defined), at
a purchase price of $26.24 per share (the “Exercise Price”), subject to adjustment from time to time pursuant to the provisions of Section 2. For purposes of this Warrant, the term “Common Stock” shall mean the $0.01 par value
common stock of the Company. 
  
 1. Exercise of Warrants.

  
 1.1 Method of Exercise. The Warrant
evidenced hereby may be exercised by the Holder, in whole or in part, by the delivery at the principal office of the Company (or at such other office or agency of the Company as it may designate by notice in writing to the Holder), during normal
business hours, of this Warrant and the Form of Exercise attached hereto as Schedule A, duly completed and executed by the Holder, and payment (by wire transfer of immediately available United States federal funds or by bank certified,
treasurer’s or cashier’s check payable to the order of the Company) of the aggregate Exercise Price for the Warrant Shares covered by such exercise. 
  

1.2 Cashless Exercise. In lieu of exercising the Warrant evidenced hereby pursuant to Section 1.1 above, the Holder shall have the right
at any time to exercise this Warrant, in whole or in part, by requiring the Company to convert this Warrant (the “Conversion Right”), into Warrant Shares by surrendering this Warrant to the Company accompanied by the Form of Conversion
Notice attached hereto as Schedule B, duly completed and executed by the Holder. Upon exercise of the Conversion Right, the Company shall deliver to the Holder (without payment by the Holder of any cash in respect of the Exercise Price) that
number of Warrant Shares which is equal to the amount obtained by dividing (x) an amount equal to the difference 







 
between (A) the aggregate Market Price for the Warrant Shares as to which the Conversion Right is then being exercised (the “Conversion Shares”),
determined as of the exercise of the Conversion Right, minus (B) the aggregate Exercise Price then applicable to the Conversion Shares (such difference, the “Conversion Amount”), by (y) the Market Price of one share of Common Stock
determined as of the exercise of the Conversion Right. Any references in this Warrant to the “exercise” of this Warrant, and the use of the term “exercise” herein, shall be deemed to include, without limitation, any exercise of
the Conversion Right.  
  
 1.3 Partial
Exercise. In the event this Warrant is not exercised in full, the total number of Warrant Shares shall be reduced by the number of Warrant Shares subject to such partial exercise, and the Company shall promptly issue and deliver to the Holder a
new Warrant of like tenor in the name of the Holder, reflecting such adjusted number of Warrant Shares.  
  
 1.4 Delivery of Certificates. The certificate for the Warrant Shares issued upon exercise of this Warrant by the Holder pursuant to Sections
1.1 or 1.2 shall be delivered to the Holder as soon as practicable after the exercise of this Warrant. The certificate evidencing the Warrant Shares shall bear a restrictive legend substantially in the form set forth below: 
  
 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE: (A) HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES LAWS; AND (B) MAY NOT BE SOLD, PLEDGED, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR AN
EXEMPTION THEREFROM UNDER THE SECURITIES ACT (INCLUDING ANY RULES OR REGULATIONS THEREUNDER) AND ANY APPLICABLE STATE SECURITIES LAWS.” 
  
 1.5 No Fractional Shares. In lieu of issuing any fractional shares of Common Stock, the Company shall pay to the Holder cash in an amount
equal to the same fraction of the Market Price of one share of Common Stock determined as of the exercise date of this Warrant. 
  
 2. Adjustments to Exercise Price and Warrant Shares. The Exercise Price and the number of Warrant Shares issuable upon the exercise of the Warrant are
subject to adjustment from time to time upon the occurrence of the events enumerated in this Section 2. 
  
 2.1 Adjustment for Change in Capital Stock. If the Company shall (i) declare a dividend on the Common Stock in shares of its capital stock
(whether shares of Common Stock or of capital stock of any other class), (ii) split or subdivide the outstanding Common Stock, (iii) combine the outstanding Common Stock into a smaller number of shares or (iv) engage in a recapitalization,
reorganization, exchange of shares, spin-off or similar change in capitalization or event, this Warrant shall entitle the Holder to receive the aggregate number and kind of shares which, if this Warrant had been exercised immediately prior to such
time, the Holder would have owned or have become entitled to receive by virtue of such change in capitalization or event at an Exercise Price adjusted for such change in the number of shares purchasable. Such adjustment shall be made successively
whenever any event listed above shall occur and, if a dividend which 

  

 2 







 
is declared is not paid, this Warrant shall again entitle the Holder to receive the number of shares of Common Stock as would have been the case had such
dividend not been declared. Notwithstanding anything to the contrary in this Section 2.1, in no event shall an adjustment to the Exercise Price pursuant to this section result in an aggregate increase in the Exercise Price. This Section 2.1 shall
not apply to any transaction to which Section 2.2 is applicable.  
  
 2.2 Adjustment for Certain Transactions. If the Company consolidates or merges with or into, or sells, transfers or leases all or substantially all of its assets to, any Person, upon consummation of such
transaction this Warrant shall automatically become exercisable in full for the kind and amount of securities, cash or other assets which the Holder of a Warrant would have been entitled to receive in connection with the consolidation, merger, sale,
transfer or lease if the Holder had exercised the Warrant immediately before the effective date of such transaction provided, however, that in the case of a consolidation or merger which would result in the voting securities of the Company
outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving or acquiring entity) at least 50% of the surviving corporation immediately after the closing
thereof, this Warrant shall remain exercisable only during the Exercise Period. Concurrently with the consummation of such transaction, the Person formed by or surviving any such consolidation or merger (if other than the Company), or the Person to
which such sale, transfer or lease shall have been made, shall enter into a supplemental Warrant so providing and further providing for adjustments which shall be as nearly equivalent as may be practical to the adjustments provided for in this
Section 2. The successor Person shall send to the Holder a notice describing the supplemental Warrant. If the issuer of securities deliverable upon exercise of the supplemental Warrant is an Affiliate (as defined in Section 13 hereof) of the formed,
surviving, transferee or lessee Person, that issuer shall join in the supplemental Warrant. Notwithstanding anything to the contrary in this Section 2.2, in no event shall there be an aggregate increase in the Exercise Price. 
  
 2.3 Termination of License Agreement. If the Holder terminates the
License Agreement pursuant to Section 18.2, 18.3 or 18.4 of such agreement, this Warrant shall automatically become exercisable in full. 
  
 2.4 Notices to Holder. 
  
 (a) Upon any adjustment of this Warrant pursuant to this Section 2, the Company shall promptly thereafter (i) cause a certificate to be
executed by the Company setting forth the Exercise Price after such adjustment and setting forth in reasonable detail the method of calculation and the facts upon which such calculations are based and setting forth the number of Warrant Shares
issuable after such adjustment in the Exercise Price, upon exercise of the Warrant in full and payment of the adjusted Exercise Price, and (ii) notify the Holder of such adjustments by sending it a copy of the certificate referenced in the preceding
clause (i). Where appropriate, such notice may be given in advance. 
  

 3 







 (b) The failure to give the notice required by this Section 2.4 or any defect therein
shall not affect the legality or validity of the transaction to which it relates. 
  
 3. Payment of Taxes. The Company shall pay all documentary stamp taxes, if any, attributable to the initial issuance of Warrant Shares upon exercise of the Warrant. The Company shall not, however, be required to pay any tax or
taxes which may be payable in respect of any transfer involved in the issuance and delivery of this Warrant, or any supplemental or replacement Warrant, or any certificate for Warrant Shares or other securities, and the Company shall not be required
to issue or deliver any such supplemental or replacement Warrants or certificates unless and until the Person(s) requesting the issuance thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of
the Company that such tax has been paid. 
  
 4. Certain
Covenants. 
  
 4.1 The Company shall at all times reserve
and keep available, free from preemptive rights, out of the aggregate of its authorized but unissued Common Stock or its authorized and issued Common Stock held in its treasury, for the purpose of enabling it to satisfy any obligation to issue
Warrant Shares upon exercise of this Warrant, the maximum number of Warrant Shares which may then be deliverable upon the exercise in full of this Warrant. 
  
 4.2 The Company shall (i) use its best efforts to comply with the current public information requirements of Rule 144 (“Rule 144”) under the
Securities Act and (ii) at all times Rule 144 is available for use by Holder, furnish the Holder upon request with all information within the possession of the Company, required for the preparation and filing of Form 144. As soon as reasonably
practicable after January 1, 2007, or at such time as the Warrant Shares otherwise become exercisable pursuant to the terms hereof, NDCHealth shall, to the extent required by the rules of the NYSE, file with the NYSE a listing application or other
notice as may be required with respect to the Warrant Shares and use its commercially reasonable efforts to obtain approval for the listing of such shares.  
  
 5. Representations and Warranties. 
  
 5.1 The Company hereby represents and warrants to the Holder as follows: 
  
 (a) This Warrant has been duly authorized by all necessary corporate action on the part of the Company and
has been duly executed by a duly authorized officer of the Company and constitutes a valid and binding obligation of the Company. 
  
 (b) Neither the execution and delivery of this Warrant, nor the consummation of the transactions contemplated hereby, will violate or
result in any violation of or be in conflict with or constitute a default under any term of the charter or bylaws of the Company or of any agreement, instrument, judgment, decree, order, statute, rule or governmental regulation applicable to the
Company. 
  

 4 







 (c) All Warrant Shares which may be issued upon the exercise of this Warrant, when issued
in accordance with the terms hereof, shall be duly authorized, validly issued, fully paid and nonassessable. 
  
 5.2 The Holder hereby represents and warrants to the Company (which shall be affirmed by the Holder on the date of the exercise of this Warrant) that (a)
this Warrant and the Warrant Shares issuable upon exercise of this Warrant (collectively, the “NDCHealth Securities”) are being acquired for the Holder’s own account, for investment purposes only, and not with a view to any
distribution or resale thereof; and (b) the Holder is a sophisticated investor with knowledge and experience in financial matters, is capable of evaluating the merits and risks of an investment in the NDCHealth Securities, has the capacity to
protect its own interests in connection with the transactions contemplated by this Agreement, is able to bear the economic risk of its investment in the NDCHealth Securities, is presently able to afford the complete loss of such investment, and is
an “accredited investor” (as defined in Rule 501 of Regulation D promulgated under the Securities Act). 
  
 6. Holder; No Rights as Shareholder. The Holder shall be deemed the owner of this Warrant for all purposes. The Holder shall not be entitled by
virtue of ownership of this Warrant to any rights whatsoever as a shareholder of the Company with respect to the Common Stock issuable upon exercise of this Warrant, either at law or in equity, including, without limitation, the right to vote and to
receive dividends and other distributions. 
  
 7. Restrictions on
Transfer. 
  
 7.1 The Holder may not Transfer this Warrant
to any Person other than an Affiliate without the express prior written consent of the Company, and any Transfer in violation of this Section 7 shall be void and of no force or effect. In the event that the Company consents to any Transfer requested
by the Holder to any Person (a “Proposed Transferee”), such Transfer shall be conditioned upon the receipt of an opinion of counsel reasonably satisfactory to the Company that such Transfer to a Proposed Transferee would not result in a
violation of the provisions of the Securities Act and applicable state securities laws. 
  
 7.2 Each Holder of this Warrant and any Warrant Shares issued upon exercise of this Warrant, by taking or holding the same, consents to and agrees to be bound by the provisions of this Section 7. 
  
 8. Lost Warrant. Upon receipt by the Company at its principal office of
evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, and in the case of any such loss, theft, or destruction, upon delivery of indemnity reasonably satisfactory to the Company or, in case of
any such mutilation, upon surrender and cancellation of this Warrant, the Company will issue a new Warrant of like tenor in lieu of this Warrant. 
  
 9. Expiration. This Warrant, in all events, shall be wholly void and have no effect after 5:00 P.M. (Eastern Standard Time) on December 31, 2008.

  

 5 







 10. Notices. All notices, consents or other communications required or permitted to be given under this
Agreement shall be in writing and shall be deemed to have been duly given (a) when delivered personally, or (b) one business day after being sent by a reputable overnight delivery service, postage or delivery charges prepaid (provided that
confirmation of delivery is obtained from such service), to the parties at their respective addresses set forth below: 
  
 If to the Company: 
  
 NDCHealth Corporation 
 NDC Plaza

 Atlanta, Georgia 30329-2010 
 Attention: Chief Executive Officer 
  
 with a copy to:

  
 Stephen E. Lewis 
 Troutman Sanders LLP 
 600 Peachtree Street,
NE, Suite 5200 
 Atlanta, Georgia 30308-2216 
  
 If to the Holder: 
  
 Arclight Systems LLC 
 c/o Brendan A. Ford

 Executive Vice President-Corporate Development 
 Cardinal Health Inc. 
 7000 Cardinal Place 
 Dublin, Ohio 43017 
  
 with a copy to: 
  
 Gary D. Gerstman 
 Sidley Austin Brown &
Wood LLP 
 Bank One Plaza 
 10
S. Dearborn Street 
 Chicago, Illinois 60603 
  
 Notices may also be given by prepaid telegram or facsimile and shall be effective on the date transmitted if confirmed within 24 hours thereafter by a
signed original sent in the manner provided above. Any party may change its address for notice and the address to which copies must be sent by giving notice of the new addresses to the other parties in accordance with this Section 10, except that
any such change of address notice shall not be effective unless and until received. 
  

 6 







 11. Severability. In the event that one or more of the provisions of this Warrant shall for any reason be
held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision of this Warrant, but this Warrant shall be construed as if such invalid, illegal or unenforceable
provision had never been contained herein. 
  
 12. Governing Law.
This Warrant shall be governed by and construed in accordance with the laws of the State of Delaware applicable to agreements made and to be entirely performed within such State without giving effect to principles of conflicts of laws. 

 
 13. Definitions. As used in this Agreement: 
  
 (a) “Affiliate” means any Person that directly or
indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Person specified. The terms “control,” “controlled by” and “under common control with” means the
possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, as general partner, as a limited partner with a right to receive fifty
percent (50%) or more of the income or assets of a limited partnership, by contract or otherwise. 
  
 (b) “Market Price” means as of the date of determination, the last sale price for the Common Stock on the principal securities
market or exchange on which the Common Stock is listed or admitted to trading averaged over a period of ten (10) consecutive trading days ending on the last trading day prior to the date of the exercise of this Warrant. If at any time the Common
Stock is not listed on any market or exchange, the Market Price of the Common Stock shall be deemed to be the higher of (i) the book value thereof, as determined in accordance with generally accepted accounting principles consistent with those then
being applied by the Company by any firm of independent certified public accountants (which may be the regular auditors of the Company) of recognized national standing selected by the Board of Directors of the Company, as of the last day of the
month ending within thirty-one (31) days preceding the date of the exercise of this Warrant, and (ii) the fair market value thereof as of a date which is within fifteen (15) days preceding the date of the exercise of this Warrant, as determined by
an independent material brokerage firm selected by the Company and reasonably acceptable to the Holder. 
  
 (c) “NYSE” means the New York Stock Exchange, Inc. 
  
 (d) “Person” means any individual, sole proprietorship, joint venture, partnership, corporation,
association, cooperative, trust, estate, governmental body, administrative agency, regulatory authority or other entity of any nature. 
  
 (e) “Transfer” means to dispose of or part with all or any portion of an interest (legal or equitable) by any means, direct or
indirect, absolute or conditional, voluntary or involuntary, including, but not limited to, by sale, assignment, disposition, court order, operation of law, dissolution, merger, consolidation, division, spin-off, dividend, distribution, equitable or
other distribution after divorce or separation, settlement, exchange, waiver, abandonment, gift, alienation, bequest, pledge, hypothecation, encumbrance or disposal. 
  

 7 







 14. Neutral Construction. The parties have negotiated this Warrant and all of the terms and conditions
contained in this Warrant in good faith and at arms’ length, and each party has been represented by counsel during such negotiations. No term, condition, or provision contained in this Agreement shall be construed against any party or in favor
of any party because such party or such party’s counsel drafted such term, condition, or provision. Furthermore, all terms, conditions, and provisions contained in this Warrant shall be construed and interpreted in a manner which is consistent
with all other terms, conditions, and provisions contained in this Warrant. 
  
 15. Counterparts. This Warrant may be executed in one or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. 
  
 IN WITNESS WHEREOF, NDCHealth Corporation and the Holder have caused
this Warrant to be signed by a duly authorized officer and dated as of December 31, 2003. 
  

	 NDCHEALTH CORPORATION

		
	 By:
	 	 
	 	

	 	 	 Randolph L.M. Hutto, Executive Vice
 President and Chief Financial Officer



  

	 ARCLIGHT SYSTEMS LLC

		
	 By:
	 	 
	 	

	 	 	Mike Buettner, Chief Financial Officer


  

 8